(Q38295108)

1 September 2017

1 reference

title

The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer (English)

1 reference

1 September 2017

1 reference

2

Jorge S Reis-Filho

1 reference

1 September 2017

3

Monica Morrow

1 reference

1 September 2017

Lisa A Newman

1

1 reference

1 September 2017

Lisa A Carey

series ordinal

4

1 reference

1 September 2017

Tari A King

series ordinal

5

1 reference

1 September 2017

publication date

20 December 2014

1 reference

Annals of Surgical Oncology

1 September 2017

published in

1 reference

1 September 2017

volume

22

1 reference

1 September 2017

issue

3

1 reference

1 September 2017

page(s)

874-882

1 reference

Triple-negative breast cancer: epidemiological considerations and recommendations

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Triple-negative breast cancer: epidemiology and management options

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Triple-negative breast cancer: an unmet medical need

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Triple-negative breast cancer: correlation between imaging and pathological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Mammography and ultrasound features of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Assessing the role of ultrasound in predicting the biological behavior of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Genetic susceptibility to triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Epidemiology of basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Reproductive risk factors and breast cancer subtypes: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Risk factors for breast cancer according to estrogen and progesterone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Association between common risk factors and molecular subtypes in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Male breast cancer according to tumor subtype and race: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Triple negative and basal-like breast cancer in East Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Biologic markers determine both the risk and the timing of recurrence in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Relative and disease-free survival for breast cancer in relation to subtype: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Outcome in breast molecular subtypes according to nodal status and surgical procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

The diverse distribution of risk factors between breast cancer subtypes of ER, PR and HER2: a 10-year retrospective multi-center study in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Histological and biological evolution of human premalignant breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Triple-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Tackling the diversity of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Refinement of breast cancer classification by molecular characterization of histological special types

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Histological and molecular types of breast cancer: is there a unifying taxonomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Metaplastic breast carcinoma: more than a special type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

A refined molecular taxonomy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Presenting features of breast cancer differ by molecular subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Breast-conserving therapy for triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Triple-negative breast cancer is not a contraindication for breast conservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Effect of margin width on local recurrence in triple-negative breast cancer patients treated with breast-conserving therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Deconstructing the molecular portraits of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4279-0

10.1245/S10434-014-4279-0

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

1038623688

0 references

1 reference